- 专利标题: Imidazothiazole derivatives as modulators of TNF activity
-
申请号: US15038986申请日: 2014-12-08
-
公开(公告)号: US10273247B2公开(公告)日: 2019-04-30
- 发明人: Rikki Peter Alexander , Mezher Hussein Ali , Julien Alistair Brown , Victoria Elizabeth Jackson
- 申请人: UCB BIOPHARMA SPRL
- 申请人地址: BE Brussels
- 专利权人: UCB Biopharma SPRL
- 当前专利权人: UCB Biopharma SPRL
- 当前专利权人地址: BE Brussels
- 代理机构: McDonnell Boehnen Hulbert & Berghoff LLP
- 优先权: GB1321731 20131209
- 国际申请: PCT/EP2014/076842 WO 20141208
- 国际公布: WO2015/086504 WO 20150618
- 主分类号: C07D513/04
- IPC分类号: C07D513/04 ; A61K31/429 ; A61K45/06
摘要:
A series of substituted imidazo[2,1-b]thiazole derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
公开/授权文献
信息查询